Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping
Open Access
- 18 September 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-12
Abstract
Amine quantification is an important strategy in patient stratification and personalised medicine. This is because amines, including amino acids and methylarginines impact on many homeostatic processes. One important pathway regulated by amine levels is nitric oxide synthase (NOS). NOS is regulated by levels of (i) the substrate, arginine, (ii) amino acids which cycle with arginine and (iii) methylarginine inhibitors of NOS. However, biomarker research in this area is hindered by the lack of a unified analytical platform. Thus, the development of a common metabolomics platform, where a wide range of amino acids and methylarginines can be measured constitutes an important unmet need. Here we report a novel high-throughput ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) platform where ≈40 amine analytes, including arginine and methylarginines can be detected and quantified on a molar basis, in a single sample of human plasma. To validate the platform and to generate biomarkers, human plasma from a well-defined cohort of patients before and after coronary artery bypass surgery, who developed systemic inflammatory response syndrome (SIRS), were analysed. Bypass surgery with SIRS significantly altered 26 amine analytes, including arginine and ADMA. Consequently, pathway analysis revealed significant changes in a range of pathways including those associated with NOS.Keywords
Funding Information
- British Heart Foundation (FS/16/1/31699, PG/15/47/31591, FS/12/53/29643, FS/16/1/31699, PG/15/47/31591)
This publication has 34 references indexed in Scilit:
- Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathwaysPLOS ONE, 2017
- Endogenous Nitric Oxide Synthase Inhibitors in the Biology of DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseCurrent Cardiology Reviews, 2010
- Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the CommunityCirculation, 2009
- Arginine Metabolism: Boundaries of Our KnowledgeThe Journal of Nutrition, 2007
- Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortalityClinical Nutrition, 2003
- Effects of nitric oxide-modulating amino acids on coronary vessels: relevance to sepsisEuropean Journal of Pharmacology, 2000
- Production of nitric oxide during surgery involving cardiopulmonary bypassCritical Care Medicine, 1998
- Expression of nitric oxide synthase in human central nervous system tumors.1995
- Nitric oxide synthase activity in human gynecological cancer.1994